Mark Lindon Attorney

First Admitted: 1985, California

Professional Webpage: http://www.lindonlaw.net/biography.html

Bar/Professional Activity:

Member of the Business Law section of the California Lawyers Association.

Transactions:

Represented LiveMore Superfoods in sale to Valle Frio SpA of Chile (a subsidiary of Empresas Copec, S.A.), and structured founder's 20% equity rollover with put/call options. , 2024
Represented Steve Hanson Landscaping in sale to Kian Capital / Diamond Landscaping., 2023
Represented Seybert’s Billiards Corporation in four strategic acquisitions from 2022 - 2024., 2024
Represented Doheny Eye Institute in creation of the RIMR AMD Consortium. , 2023
Represented Edge Capital in acquisition of Cruise & Tour , 2022
Represented executive officer in restructuring of private equity portfolio company, 2022
Represented AndMark Management and AndMark Investment Fund VI private equity fund in $150 million private offering., 2022
Represented closely-held defendant corporation in shareholder litigation, created strategy for and successfully executed taking control of Board and worked with litigation counsel to settle case, 2022
Represented Moa Capital (private equity) in acquisition of Seybert’s Billiards Corporation., 2021
Represented G64 Ventures in sale of ArborBridge (online test prep & tutoring) to Private Prep, 2021
Represented Trillen Medical in license of medtech IP from The Regents of the University of California through the UCLA Technology Development Group , 2021
Represented Moa Capital in acquisition of PriMetrica (leading telecom market research and analysis company), 2021
Represented G64 Ventures in acquisition of in acquisition of PanicTap safety device, 2020
Represented executive officer joining private equity portfolio company, restructured deal for tax efficiency, and contingent equity control agreement, 2020
Represented PERC equity owners in sale of minority equity interest to Essilor Labs (a subsidiary of EssilorLuxottica) , 2020
Represented PerQflo (Al Mann microinfusion pump medtech company) in sale to Medtronic, 2019
Represented Chaser Brand (apparel company) in multiple acquisitions , 2019
Represented PERC equity owners in structuring multi-year put/call options on owners' minority equity interests with Essilor Labs (a subsidiary of EssilorLuxottica) , 2016
Represented PERC eyecare GPO in sale of majority equity to Essilor Labs (a subsidiary of EssilorLuxottica), and negotiated operating agreement safeguards and restrictions protecting minority interests, 2016
Represented Doheny Eye Institute in connection with a multi-year Technology and Intellectual Property Rights License Agreement with a Chinese ophthalmic center licensee., 2015
Represented PERC (Professional Eyecare Resource Co-operative) eyecare GPO entities in corporate restructuring., 2015
Represented Al Mann in debt restructuring of Eclipse Aerospace, 2014
Represented Doheny Eye Institue in its 99-year affiliation with UCLA Health and the Jules Stein Eye Institute, 2013
Represented Quallion (Al Mann medtech aerospace and defense battery and power solutions co.) in sale to EnerSys Power Solutions, 2013
Represented Stellar Microelectronics (Al Mann microelectronics manufacturer) in sale to Flex, 2012
Represented Bioness in licensing $100 million microstimulator device and related manufacturing rights agreement, 2008
Represented Bioness (Al Mann neuromodulation medtech company) in its 15-month acquisition of NESS (prominent Israeli medical device manufacturer), 2007

Educational Background:

Mark received his A.B. degree from Georgetown University where he graduated magna cum laude in interdisciplinary studies (government, economics and philosophy) and played rugby for seven seasons.

Other Outstanding Achievements:

CO-FOUNDER, GENERAL COUNSEL and STRATEGIC ADVISOR of ANDMARK MANAGEMENT private equity, from 2015 to present. The six ANDMARK FUNDS (managed by AndMark Management) have engaged in $1.5 - $2 billion of real estate investment transactions (purchases, financings and sales). , 2025
CHAIRMAN OF THE BOARD of BIONESS INC. from 2017 to 2021. BIONESS is a prominent medical device company in Valencia, CA. Bioness was founded by and majority-owned by Alfred E. Mann, world-renowned entrepreneur and medical device multi-billionaire. It was sold in 2021., 2021
BOARD OF DIRECTORS of BIONESS INC. Board member from 2016 until 2021. Bioness is a prominent medical device company in Valencia, CA. Bioness was founded by and majority-owned by Alfred E. Mann, world-renowned entrepreneur and medical device multi-billionaire. It was sold in 2021., 2021
BOARD OF DIRECTORS of BIONESS NEUROMODULATION, LTD., from 2017-2021. BIONESS NEUROMODULATION is the Israeli subsidiary of BIONESS INC., a prominent medical device company in Valencia, CA founded by and majority-owned by Alfred E. Mann, world-renowned entrepreneur and medical device multi-billionaire. , 2021

Industry Groups:

Apparel
Finance
Healthcare Affiliations
Medical Devices
Mobile Applications
Personal Care and Manufacturing
Private Equity
Technology

Contact Mark

All the below fields are required